US FDA Advisory Committee votes to support effectiveness and safety of GSK’s respiratory syncytial virus older adult vaccine candidate

SaponiQx’s QS-21 STIMULON™ is a key adjuvant component in GSK’s Shingrix and Arexvy vaccines, leading vaccines in the prevention of Shingles and RSV.